Structure

InChI Key RVCSYOQWLPPAOA-QKYUOBHYSA-M
Smile O=C(O[C@@H]1C[C@@H]2CC[C@H](C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1.[Cl-]
InChI
InChI=1S/C25H30NO3.ClH/c27-24(25(28,19-9-3-1-4-10-19)20-11-5-2-6-12-20)29-23-17-21-13-14-22(18-23)26(21)15-7-8-16-26;/h1-6,9-12,21-23,28H,7-8,13-18H2;1H/q+1;/p-1/t21-,22+,23+;

Physicochemical Descriptors

Property Name Value
Molecular Formula C25H30ClNO3
Molecular Weight 427.97
AlogP 3.77
Hydrogen Bond Acceptor 3.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 4.0
Polar Surface Area 46.53
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 29.0

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Muscarinic acetylcholine receptor M2 antagonist PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Schizophrenia 3 D012559 ClinicalTrials
Pulmonary Disease, Chronic Obstructive 1 D029424 ClinicalTrials

Related Entries

Scaffolds

Parent

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Nervous system disorders
17.86
Psychiatric disorders
12.81
General disorders and administration site conditions
11.58
Gastrointestinal disorders
9.98
Cardiac disorders
5.54
Injury, poisoning and procedural complications
5.3
Skin and subcutaneous tissue disorders
5.17
Renal and urinary disorders
4.68
Respiratory, thoracic and mediastinal disorders
4.06
Musculoskeletal and connective tissue disorders
3.94
Vascular disorders
3.82
Immune system disorders
2.71
Eye disorders
2.09
Infections and infestations
2.09

Cross References

Resources Reference
ChEBI 32270
ChEMBL CHEMBL3084748
EPA CompTox DTXSID7023724
FDA SRS 1E6682427E
SureChEMBL SCHEMBL25785